期刊文献+

S100A12-RAGE途径检测对重度子痫前期的意义 被引量:5

原文传递
导出
摘要 目的:检测正常妊娠妇女及重度子痫前期患者血清中S100A12蛋白及可溶性晚期糖基化终末产物受体(sRAGE)蛋白的表达水平,并探讨在重度子痫前期两者与临床资料、血生化指标及胎盘RAGE蛋白表达的相关性。方法:选择2011年2月~2012年4月该院收治的重度子痫前期患者20例为观察组,同期正常早期妊娠妇女18例、中期妊娠妇女20例、晚期妊娠妇女20例为对照组,ELISA方法检测各组血清S100A12表达水平,Western blot测定观察组患者及正常晚期妊娠妇女胎盘RAGE蛋白的表达,ELISA方法检测观察组患者及正常中期妊娠妇女sRAGE表达水平,测定两组血生化指标,并分析重度子痫前期患者血清S100A12及sRAGE水平与临床资料、血生化指标及胎盘RAGE表达的相关性。结果:观察组患者血清S100A12高于各对照组,差异有统计学意义(P〈0.01),血清sRAGE、尿酸、TC、TG水平升高,差异有统计学意义(P均〈0.05),胎盘RAGE表达水平及血清肌酐、LDL-C水平明显升高,差异有统计学意义(P均〈0.01);观察组患者血清S100A12水平与尿酸水平呈正相关(P〈0.01),与胎盘RAGE表达呈正相关(P〈0.05);sRAGE水平与血清肌酐、尿酸、HDL-C、胎盘RAGE表达呈正相关(P均〈0.05)。结论:重度子痫前期患者体内RAGE系统激活,血清S100A12蛋白及sRAGE水平升高,且与血生化指标、胎盘RAGE表达有一定相关性,在子痫前期的发生发展中发挥了重要作用。
出处 《中国妇幼保健》 CAS 北大核心 2014年第32期5346-5348,共3页 Maternal and Child Health Care of China
基金 石家庄市科学研究与发展计划〔101461403〕
  • 相关文献

参考文献11

  • 1王建梅,朱锦明,丁玉红.子痫前期对新生儿的影响[J].中国妇幼保健,2013,28(16):2569-2571. 被引量:7
  • 2陈敏玲,狄君平,叶娇君.妊娠期糖尿病患者胎盘中HGF、RAGE的表达及临床意义[J].中国妇幼保健,2013,28(20):3344-3346. 被引量:6
  • 3Naruse K, Sado T,Noguchi T, et al. Peripheral RAGE ( re-ceptor for advanced glycation endproducts) - ligands in nor-mal pregnancy and preeclampsia ; novel markers of inflammato-ry response [J] . J Reprod Immunol,2012, 93 (2) : 69 -74.
  • 4Buhimschi IA,Zhao G,Pettker CM,et al. The receptor foradvanced glycation end products ( RAGE) system in womenwith intraamniotic infection and inflammation[ J]. Am J Ob-stet Gynecol, 2007, 196 (2): 181. el - 13.
  • 5Arumugam T, Simeone DM, Schmidt AM, et al. SI OOP stimu-lates cell proliferation and survival via receptor for activatedglycation end products (RAGE ) [ J]. J Biol Chem,2004,279 (7): 5059-5065.
  • 6Lin L,Park S,Lakatta EG. RAGE signaling in inflammationand arterial aging [ J) . Front Biosci,2009, 14: 1403 -1413.
  • 7Little RE, Gladen BC. Levels of lipid peroxides in uncomplicat-ed pregnancy : a review of the literature[ J]. Reprod Toxicol,1999,139 (5): 347 -352.
  • 8Lok CA,Jebbink J,Nieuwland R,et al. Leukocyte activationand circulating leukocyte - derived microparticles in preeclamp-sia [J]. Am J Reprod Immunol, 2009, 61 ( 5 ) : 346 -359.
  • 9Bianchi ME. DAMPs,PAMPs and alarmins : all we need toknow about danger[J]. J Leukoc Biol, 2007, 81 ( 1 ):1-5.
  • 10宋春红,赵松,梁珊,王莉.血清sRAGE检测对妊娠高血压综合征的意义[J].山东医药,2012,52(24):88-89. 被引量:6

二级参考文献20

  • 1应豪,王德芬.孕28至32周重度妊高征的期待治疗[J].现代妇产科进展,2004,13(6):449-452. 被引量:57
  • 2沈晓明,王卫平.儿科学[M].第7版,北京:人民卫生出版社,2010.136.
  • 3乐杰.妇产科学[M]5版[M].北京:人民卫生出版社,2001.129.
  • 4Yamagishi S, Matstti T. Soluble form of a receptor for advanced giy- cation end products (sRAGE) as a biomarker [ J ]. Front Biosci (Elite Ed), 2010,2:1184-1195.
  • 5Germanov~t A, Koucky M, H6jek Z, et al. Soluble receptor for ad- vanced glycation end products in physiological and pathological preg- nancy [ J ]. Clin Biochem, 2010,43 (4-5) :442-446.
  • 6Nakamura K, Yamagishi S, Adachi H, et al. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes [J]. Mol Med, 2007,13(3-4):185-189.
  • 7Tan KCB, Shiu SWM, Chow WS, et al. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes [ J]. Diabetologia, 2006,49( 11 ) :2756-2762.
  • 8Kalousovs M, Hodkova M, Kazderova M, et al. Soluble receptor for advanced glycation end products in patients with decreased renal function [J]. Am J Kidney Dis, 2006,47(3) :406-411.
  • 9Suliman ME, Heimbtirger O, Baray P, et al. Plasma peritosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy [ J]. J Am Soc Nephrol, 2003,14(6) :1614-1622.
  • 10Semba RD, Ferrucci L, Fink JC, et al. Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women [J]. Am J Kidney Dis, 2009, 53(1) :51-58.

共引文献16

同被引文献71

  • 1卢莉萍,李忠祥,戴淑玲,臧玉芹,高翠美.低分子肝素对重度子痫前期患者肾功能保护作用的临床探讨[J].中国妇产科临床杂志,2007,8(6):423-425. 被引量:25
  • 2World Health Orgnization[M].The World Health Re Port,2002.
  • 3WBI,Getting health reform right-flagshi P training course[M].World Bank,2002.
  • 4BAKER P N,SMITH S C,SYMONDS E M,et al.Placental a Po Ptosis innormal human Preganacy[J].American Journal of Obstetrics and Gynecology,1997,177(1):5.
  • 5SHIOZAKI A K,FUJIMURA M,YUKI H,et al.Survivin inhibits a Po Ptosis in cytotro Phoblasts[J].Placenta,2003,24(1):65-76.
  • 6HUNG T H,CHARNOCK D S,SKEPPER J N,et al.Secretion of tumor necrosis factor-al Pha from human Placental tissues induced by hy Poxia-reoxygenation causes endothelial cell activation in vitro:a Potiential mediator of the inflammatory res Ponse in Preeclam Psia[J].American Journal of Pathology,2004,164(3):1049-1061.
  • 7KOLIALEXI A,ANAGNOSTOPOULOS A K,MAVROU A,et al.Application of proteomics for diagnosis of fetal aneuploidies and pregnancy complications[J].Journal of Proteomics,2009,72(5):731-739.
  • 8SCHULZ C,SCHAFER A,STOLLA M,et al.Chemokine fi'actalkine mediates leukocyte recruitmentto inflammatory endothelial cells in flowing whole blood:a criileal role for P.selectinex Pressed on activated Platelets[J].Circulation,2007,116(7):764-773.
  • 9谢谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2012:15-18.
  • 10Salimi S, Yaghmaei M, Tabatabaei E, et al. Vascular endo- thelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level[J]. J Obstet Gynaecol Res, 2015,21 (2) : 78- 82.

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部